65
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Aerosolized recombinant human lysozyme ameliorates pseudomonas aeruginosa–induced pneumonia in hamsters

, , , &
Pages 94-100 | Received 13 Apr 2009, Accepted 30 Jun 2009, Published online: 05 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karl E Griswold, Jenna L Bement, Charlotte C Teneback, Thomas C Scanlon, Matthew J Wargo & Laurie W Leclair. (2014) Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections. Bioengineered 5:2, pages 143-147.
Read now
Tapan Bhavsar, Ming Liu, Xingjian Liu & Jerome Cantor. (2011) Aerosolized recombinant human lysozyme enhances the bactericidal effect of tobramycin in a hamster model of pseudomonas aeruginosa–induced pneumonia. Experimental Lung Research 37:9, pages 536-541.
Read now

Articles from other publishers (17)

Jaclyn Kelly Mann, Tarylee Reddy, Mary van der Stok, Ayanda Ngubane, Takalani Mulaudzi, Nobuhle Mchunu, Portia Nevhungoni, Nithendra Manickchund, Pariva Manickchund, Chelline Helena Louise Cairns, Vaneshree Govender, Thumbi Ndung'u, Mahomed Yunus Suleman Moosa & Bernadett Isabel Gosnell. (2023) Hen egg white bovine colostrum supplement reduces symptoms of mild/moderate COVID-19: a randomized control trial. Future Science OA 9:8.
Crossref
María Escobar‐Salom, Gabriel Torrens, Elena Jordana‐Lluch, Antonio Oliver & Carlos Juan. (2022) Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram ‐negatives . Biological Reviews 97:3, pages 1005-1037.
Crossref
Patrizia Ferraboschi, Samuele Ciceri & Paride Grisenti. (2021) Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic. Antibiotics 10:12, pages 1534.
Crossref
Jaclyn Kelly Mann & Thumbi Ndung'u. (2020) The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19. Future Virology 15:9, pages 609-624.
Crossref
Gabriel Torrens, Maria Escobar-Salom, Antonio Oliver & Carlos Juan. (2020) Activity of mammalian peptidoglycan-targeting immunity against Pseudomonas aeruginosa. Journal of Medical Microbiology 69:4, pages 492-504.
Crossref
Sai Wen, Dongmei Yao, Xiaoyu Liu & Fenghuan Wang. (2019) A Novel Fluorescence Resonance Energy Transfer-Based High-Throughput Screening Method for Generation of Lysozyme with Improved Antimicrobial Activity against Escherichia coli Strains . Journal of Agricultural and Food Chemistry 67:45, pages 12584-12589.
Crossref
Nina Dickerhof, Vivienne Isles, Philip Pattemore, Mark B. Hampton & Anthony J. Kettle. (2019) Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis. Journal of Biological Chemistry 294:36, pages 13502-13514.
Crossref
Colleen S. Curran, Thomas Bolig & Parizad Torabi-Parizi. (2018) Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection . American Journal of Respiratory and Critical Care Medicine 197:6, pages 708-727.
Crossref
Lise Schoonen, Sjors Maassen, Roeland J. M. Nolte & Jan C. M. van Hest. (2017) Stabilization of a Virus-Like Particle and Its Application as a Nanoreactor at Physiological Conditions. Biomacromolecules 18:11, pages 3492-3497.
Crossref
Balázs Rada. (2017) Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis. Pathogens 6:1, pages 10.
Crossref
Milankumar V Prajapati, Olujoba O Adebolu, Benjamin M Morrow & Joseph M Cerreta. (2016) Original Research: Evaluation of pulmonary response to inhaled tungsten (IV) oxide nanoparticles in golden Syrian hamsters. Experimental Biology and Medicine 242:1, pages 29-44.
Crossref
Misty Good, Jay K. Kolls & Kerry McGarr Empey. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology 1262 1293.e12 .
Sarah M. Dostal, Yongliang Fang, Jonathan C. Guerrette, Thomas C. Scanlon & Karl E. Griswold. (2015) Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein. ACS Chemical Biology 10:4, pages 1110-1117.
Crossref
Daniel C. Osipovitch & Karl E. Griswold. (2014) Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiology Letters 362:2, pages 1-7.
Crossref
Vivian Tullio, Roberta Spaccapelo & Manuela Polimeni. 2015. Human and Mosquito Lysozymes. Human and Mosquito Lysozymes 45 57 .
Charlotte C. Teneback, Thomas C. Scanlon, Matthew J. Wargo, Jenna L. Bement, Karl E. Griswold & Laurie W. Leclair. (2013) Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection. Antimicrobial Agents and Chemotherapy 57:11, pages 5559-5564.
Crossref
John W. Lamppa, Sam A. Tanyos & Karl E. Griswold. (2013) Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme. Journal of Biotechnology 164:1, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.